ORG Partners’s Eli Lilly LLY Stock Holding History

ORG Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.44M	Buy	1,335 +26	+2%	+$24.9K	0.25%	91
2025 Q3	$1,000K	Sell	1,309 -21	-2%	-$15.6K	0.18%	115
2025 Q2	$1.03M	Sell	1,330 -122	-8%	-$94.8K	0.22%	94
2025 Q1	$1.17M	Sell	1,452 -104	-7%	-$86.5K	0.29%	70
2024 Q4	$1.2M	Buy	1,556 +397	+34%	+$329K	0.16%	101
2024 Q3	$1.03M	Sell	1,159 -1,057	-48%	-$950K	0.16%	104
2024 Q2	$2.02M	Buy	2,216 +2,195	+10,452%	+$1.76M	0.25%	77
2024 Q1	$16.2K	Sell	21 -3,267	-99%	-$2.33M	0.03%	243
2023 Q4	$1.92M	Buy	3,288 +1,352	+70%	+$789K	0.32%	61
2023 Q3	$1.04M	Buy	1,936 +348	+22%	+$179K	0.31%	79
2023 Q2	$741K	Buy	+1,588	New	+$666K	0.12%	160

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ORG Partners's LLY Position: Q4 2025 in Review

ORG Partners increased its Eli Lilly (LLY) stake by 2% in Q4 2025, buying an estimated $24.9K and bringing the position to 1,335 shares worth $1.44M. The position accounts for 0.25% of the portfolio, ranked #91.

ORG Partners first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. The position peaked at $2.02M in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

ORG Partners held 1,335 shares of Eli Lilly worth $1.44M as of Q4 2025.
ORG Partners bought 26 Eli Lilly shares in Q4 2025, an estimated $24.9K.
Eli Lilly made up 0.25% of ORG Partners's portfolio in Q4 2025, its #91 holding.
ORG Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
ORG Partners's Eli Lilly position peaked at $2.02M in Q2 2024.
4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.